Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
Prevalence of Chronic Hepatitis B Virus Infection in the United States
Joseph K Lim1, Mindie H Nguyen2, W Ray Kim2
1Yale Viral Hepatitis Program, Section of Digestive Diseases/Yale Liver Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Insights
An estimated 1.59 million people in the US have chronic hepatitis B virus (HBV) infection. This updated prevalence estimate is crucial for informing hepatitis B elimination strategies and prevention efforts.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health Epidemiology
Background:
- Chronic hepatitis B virus (HBV) infection is a significant global health concern, leading to severe liver conditions like cirrhosis and liver cancer.
- Despite available interventions, the prevalence of chronic HBV remains high in the United States, necessitating updated epidemiological data.
Purpose of the Study:
- To conduct an updated literature review and develop a contemporary prevalence range estimate for chronic HBV infection in the US.
- To inform the World Health Organization (WHO) and US Department of Health and Human Services (DHHS) hepatitis elimination plans with current epidemiological insights.
Main Methods:
- A panel of leading US hepatologists performed a comprehensive review of peer-reviewed literature on HBV prevalence.
- Findings were discussed and synthesized during a live HBV epidemiology workshop in May 2019.
Main Results:
- The estimated prevalence of chronic HBV infection in the US is 1.59 million persons.
- The proposed prevalence range for chronic HBV infection in the US is 1.25 to 2.49 million persons.
Conclusions:
- The updated prevalence estimate provides critical data for national hepatitis B elimination initiatives.
- Findings support the need for enhanced HBV screening and prevention strategies within the United States.
Abstract:
Chronic hepatitis B virus (HBV) infection represents a major global health problem, affecting an estimated 257-291 million persons worldwide and is associated with substantial morbidity and mortality because of clinical complications, such as liver cirrhosis and hepatocellular carcinoma. Despite existing resources for vaccination, screening, and treatment, the burden of chronic HBV remains significant within the United States (US). Both the World Health Organization (WHO) and US Department of Health and Human Services (DHHS) have articulated formal hepatitis elimination plans, although an updated assessment of the epidemiology and prevalence of chronic HBV is needed to inform these initiatives. The Chronic Liver Disease Foundation (CLDF), a nonprofit 501(c)(3) educational organization dedicated to raising awareness of liver disease, partnered with a panel of leading US hepatologists to conduct an updated literature review to develop a contemporary HBV prevalence range estimate. Panel members researched and evaluated the peer-reviewed literature on HBV prevalence and, in May 2019, discussed their findings during a live HBV epidemiology workshop. The panel proposed an overall estimated prevalence for chronic HBV infection in the US of 1.59 million persons (range 1.25-2.49 million). This review provides a summary of the workshop findings and conclusions, which may serve to inform future initiatives focused on HBV screening and prevention in the US.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

